228 related articles for article (PubMed ID: 25257531)
1. Methylphenidate ameliorates depressive comorbidity in ADHD children without any modification on differences in serum melatonin concentration between ADHD subtypes.
Cubero-Millán I; Molina-Carballo A; Machado-Casas I; Fernández-López L; Martínez-Serrano S; Tortosa-Pinto P; Ruiz-López A; Luna-del-Castillo JD; Uberos J; Muñoz-Hoyos A
Int J Mol Sci; 2014 Sep; 15(9):17115-29. PubMed ID: 25257531
[TBL] [Abstract][Full Text] [Related]
2. Methylphenidate effects on blood serotonin and melatonin levels may help to synchronise biological rhythms in children with ADHD.
Molina-Carballo A; Naranjo-Gómez A; Uberos J; Justicia-Martínez F; Ruiz-Ramos MJ; Cubero-Millán I; Contreras-Chova F; Augustin-Morales MD; Khaldy-Belkadi H; Muñoz-Hoyos A
J Psychiatr Res; 2013 Mar; 47(3):377-83. PubMed ID: 23088865
[TBL] [Abstract][Full Text] [Related]
3. BDNF concentrations and daily fluctuations differ among ADHD children and respond differently to methylphenidate with no relationship with depressive symptomatology.
Cubero-Millán I; Ruiz-Ramos MJ; Molina-Carballo A; Martínez-Serrano S; Fernández-López L; Machado-Casas I; Tortosa-Pinto P; Ruiz-López A; Luna-Del-Castillo JD; Uberos J; Muñoz-Hoyos A
Psychopharmacology (Berl); 2017 Jan; 234(2):267-279. PubMed ID: 27807606
[TBL] [Abstract][Full Text] [Related]
4. Differential responses of two related neurosteroids to methylphenidate based on ADHD subtype and the presence of depressive symptomatology.
Molina-Carballo A; Justicia-Martínez F; Moreno-Madrid F; Cubero-Millán I; Machado-Casas I; Moreno-García L; León J; Luna-Del-Castillo JD; Uberos J; Muñoz-Hoyos A
Psychopharmacology (Berl); 2014 Sep; 231(17):3635-45. PubMed ID: 24599397
[TBL] [Abstract][Full Text] [Related]
5. Indole Tryptophan Metabolism and Cytokine S100B in Children with Attention-Deficit/Hyperactivity Disorder: Daily Fluctuations, Responses to Methylphenidate, and Interrelationship with Depressive Symptomatology.
Fernández-López L; Molina-Carballo A; Cubero-Millán I; Checa-Ros A; Machado-Casas I; Blanca-Jover E; Jerez-Calero A; Madrid-Fernández Y; Uberos J; Muñoz-Hoyos A
J Child Adolesc Psychopharmacol; 2020 Apr; 30(3):177-188. PubMed ID: 32048862
[No Abstract] [Full Text] [Related]
6. Long-acting methylphenidate has an effect on aggressive behavior in children with attention-deficit/hyperactivity disorder.
Sinzig J; Döpfner M; Lehmkuhl G; ; Uebel H; Schmeck K; Poustka F; Gerber WD; Günter M; Knölker U; Gehrke M; Hässler F; Resch F; Brünger M; Ose C; Fischer R
J Child Adolesc Psychopharmacol; 2007 Aug; 17(4):421-32. PubMed ID: 17822338
[TBL] [Abstract][Full Text] [Related]
7. Attention-deficit/hyperactivity disorder and comorbid subsyndromal depression: what is the impact of methylphenidate on mood?
Golubchik P; Kodesh A; Weizman A
Clin Neuropharmacol; 2013; 36(5):141-5. PubMed ID: 24045603
[TBL] [Abstract][Full Text] [Related]
8. Effect of Methylphenidate on Emotional Dysregulation in Children With Attention-Deficit/Hyperactivity Disorder + Oppositional Defiant Disorder/Conduct Disorder.
Kutlu A; Akyol Ardic U; Ercan ES
J Clin Psychopharmacol; 2017 Apr; 37(2):220-225. PubMed ID: 28225747
[TBL] [Abstract][Full Text] [Related]
9. The effect of methylphenidate on anxiety and depression symptoms in patients with Asperger syndrome and comorbid attention deficit/hyperactivity disorder.
Golubchik P; Rapaport M; Weizman A
Int Clin Psychopharmacol; 2017 Sep; 32(5):289-293. PubMed ID: 28368900
[TBL] [Abstract][Full Text] [Related]
10. Better efficacy for the osmotic release oral system methylphenidate among poor adherents to immediate-release methylphenidate in the three ADHD subtypes.
Chou WJ; Chou MC; Tzang RF; Hsu YC; Gau SS; Chen SJ; Wu YY; Huang YF; Liang HY; Cheng H
Psychiatry Clin Neurosci; 2009 Apr; 63(2):167-75. PubMed ID: 19335386
[TBL] [Abstract][Full Text] [Related]
11. ADHD in childhood epilepsy: Clinical determinants of severity and of the response to methylphenidate.
Rheims S; Herbillon V; Villeneuve N; Auvin S; Napuri S; Cances C; Berquin P; Castelneau P; Nguyen The Tich S; Villega F; Isnard H; Nabbout R; Gaillard S; Mercier C; Kassai B; Arzimanoglou A;
Epilepsia; 2016 Jul; 57(7):1069-77. PubMed ID: 27237724
[TBL] [Abstract][Full Text] [Related]
12. Effects of behavioral and pharmacological therapies on peer reinforcement of deviancy in children with ADHD-only, ADHD and conduct problems, and controls.
Helseth SA; Waschbusch DA; Gnagy EM; Onyango AN; Burrows-MacLean L; Fabiano GA; Coles EK; Chacko A; Wymbs BT; Walker KS; Wymbs FA; Garefino A; Massetti GM; Robb Mazzant J; Hoffman MT; Waxmonsky JG; Nichols-Lopez K; Pelham WE
J Consult Clin Psychol; 2015 Apr; 83(2):280-292. PubMed ID: 25495357
[TBL] [Abstract][Full Text] [Related]
13. Randomized, Double-Blind, Placebo-Controlled Acute Comparator Trials of Lisdexamfetamine and Extended-Release Methylphenidate in Adolescents With Attention-Deficit/Hyperactivity Disorder.
Newcorn JH; Nagy P; Childress AC; Frick G; Yan B; Pliszka S
CNS Drugs; 2017 Nov; 31(11):999-1014. PubMed ID: 28980198
[TBL] [Abstract][Full Text] [Related]
14. Methylphenidate treatment of attention deficit hyperactivity disorder in young people with learning disability and difficult-to-treat epilepsy: evidence of clinical benefit.
Fosi T; Lax-Pericall MT; Scott RC; Neville BG; Aylett SE
Epilepsia; 2013 Dec; 54(12):2071-81. PubMed ID: 24304474
[TBL] [Abstract][Full Text] [Related]
15. Effect of OROS methylphenidate on encopresis in children with attention-deficit/hyperactivity disorder.
Yılmaz S; Bilgiç A; Hergüner S
J Child Adolesc Psychopharmacol; 2014 Apr; 24(3):158-60. PubMed ID: 24168715
[TBL] [Abstract][Full Text] [Related]
16. Effects of methylphenidate on subtypes of attention-deficit/hyperactivity disorder.
Gorman EB; Klorman R; Thatcher JE; Borgstedt AD
J Am Acad Child Adolesc Psychiatry; 2006 Jul; 45(7):808-16. PubMed ID: 16832317
[TBL] [Abstract][Full Text] [Related]
17. The effect of methylphenidate on oppositional defiant disorder comorbid with attention deficit/hyperactivity disorder.
Serra-Pinheiro MA; Mattos P; Souza I; Pastura G; Gomes F
Arq Neuropsiquiatr; 2004 Jun; 62(2B):399-402. PubMed ID: 15273834
[TBL] [Abstract][Full Text] [Related]
18. Attention deficit/hyperactivity disorder in adults.
Moss SB; Nair R; Vallarino A; Wang S
Prim Care; 2007 Sep; 34(3):445-73, v. PubMed ID: 17868755
[TBL] [Abstract][Full Text] [Related]
19. High pretreatment cognitive impulsivity predicts response of oppositional symptoms to methylphenidate in patients with attention-deficit hyperactivity disorder/oppositional defiant disorder.
Golubchik P; Shalev L; Tsamir D; Manor I; Weizman A
Int Clin Psychopharmacol; 2019 May; 34(3):138-142. PubMed ID: 30640748
[TBL] [Abstract][Full Text] [Related]
20. Empathy and Facial Expression Recognition in Children With and Without Attention-Deficit/Hyperactivity Disorder: Effects of Stimulant Medication on Empathic Skills in Children with Attention-Deficit/Hyperactivity Disorder.
Gumustas F; Yilmaz I; Yulaf Y; Gokce S; Sabuncuoglu O
J Child Adolesc Psychopharmacol; 2017 Jun; 27(5):433-439. PubMed ID: 28332851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
